Business / Finance

RSS

Caribou Biosciences grants IDT worldwide rights to commercialize CRISPR-Cas9 reagents

Caribou Biosciences, Inc., a developer of CRISPR technologies for precision cell engineering, and Integrated DNA Technologies, Inc., a producer of custom synthetic oligonucleotide-based technologies for genomics applications, have entered into a non-exclusive license agreement under which Caribou has granted IDT worldwide rights to commercialize CRISPR-Cas9 reagents under Caribou’s intellectual property.

24 Feb 2016

New study shows beneficial effects of fish consumption during pregnancy

A new study supports the theory that the detrimental effects of low-level exposure to mercury may be outweighed by the beneficial effects of fish consumption.

24 Feb 2016

WebMD Health reports record revenue, earnings for fourth quarter and full year 2015

WebMD Health Corp., the leading source of health information, today announced fourth quarter and full year financial results for 2015.

24 Feb 2016

Diversigen, Baylor Miraca to provide customers access to targeted genomics and metabolomics services

Diversigen, Inc., the leading provider of comprehensive microbiome analysis services, today announced a strategic partnership with Baylor Miraca Genetics Laboratories, a global leader in genetic testing, to provide their customers access to a broad range of targeted genomics and metabolomics services.

23 Feb 2016

Regulus reports net loss of $7.2 million for fourth quarter 2015

Regulus Therapeutics Inc., a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs, today reported financial results for the fourth quarter and full-year ended December 31, 2015 and provided a summary of recent corporate highlights.

23 Feb 2016

ResMed announces definitive agreement to acquire Brightree

ResMed, the world's leading tech-driven medical device company and innovator in sleep-disordered breathing and respiratory care, today announced a definitive agreement to acquire privately held Brightree, a leader in business management and clinical software applications for the post-acute care industry.

From ResMed Corp 22 Feb 2016

Amarantus BioScience Holdings closes $3M investment

Amarantus BioScience Holdings, Inc., a biotechnology company developing products in Regenerative Medicine, Neurology and Orphan diseases, today announced the closing of a $3M investment from an institutional investor. Under the terms of the agreement, the investor will be issued $3.3M worth of Series H Convertible Preferred Stock (including 10% original issue discount) from the Company and five year warrants exercisable for 13,200,000 shares of common stock at $0.40 per share.

22 Feb 2016

BistroMD, Fitness Icon Denise Austin partner to create branded meal-delivery program

BistroMD, the leader in home diet meal delivery, announced a licensing partnership today with Fitness Icon Denise Austin to create a branded meal-delivery program. The program is a natural extension of bistroMD's mission to empower people to lose weight while eating great tasting, nutritious foods, and blends with Denise's healthy lifestyle philosophy.

22 Feb 2016

Select Medical Holdings, Kindred Healthcare agree to exchange five long term acute care hospitals

Select Medical Holdings Corporation today announced that it has signed a definitive agreement to exchange five of its long term acute care hospitals for four long term acute care hospitals currently operated by Kindred Healthcare, Inc. and $800,000 in cash consideration.

18 Feb 2016

BiondVax gains additional support from NATI for ongoing development of Universal Flu Vaccine

BiondVax Pharmaceuticals Ltd. announced today that the National Authority for Technological Innovation, formerly known as the Office of the Chief Scientist, agreed to fund up to 40% of a NIS 3.6 million (US$920,000) project towards ongoing development of the Company's Universal Flu Vaccine.

18 Feb 2016

Corvidia Therapeutics secures $26 million in Series A financing

Corvidia Therapeutics, a biotechnology company focused on the development of precision cardiovascular therapies, announced today that it has raised $26 million in a Series A financing, co-led by seed-investor Sofinnova Partners, and Apple Tree Partners.

18 Feb 2016

Enzyme screening kits and samples global distribution agreement signed between Strem and Novozymes

Strem Chemicals, Inc., a manufacturer of specialty chemicals for research and development, and Novozymes, the world’s largest producer of industrial enzymes, today announced the signing of a distribution agreement.

17 Feb 2016

Creating NGS solutions in routine clinical diagnostics

Sophia Genetics, the global leader in Data-Driven Medicine (DDM), announced today the signing of a new strategic partnership with Integrated DNA Technologies (IDT).

From Integrated DNA Technologies 17 Feb 2016

BioTek to be Awarded 2015 Governor’s Excellence in Worksite Wellness

Continuing a proud tradition, BioTek Instruments will receive the 2015 Governor’s Excellence in Worksite Wellness Award, presented by the Governor’s Council on Physical Fitness and Sports.

17 Feb 2016

AMRI's net revenues increase $126.4M to 46% in fourth quarter 2015

AMRI today reported financial and operating results for the fourth quarter and full year ended December 31, 2015 and provided an outlook for 2016.

17 Feb 2016

Asterias Biotherapeutics simplifies capital structure through previously announced Asset Swap with BioTime

Asterias Biotherapeutics, Inc., a clinical-stage regenerative medicine company with a focus on pluripotent stem cell technology, today simplified its capital structure through the previously announced Asset Swap with BioTime, Inc.

17 Feb 2016

CTI BioPharma announces Q4 and FY 2015 earnings

CTI BioPharma Corp. today reported financial results for the fourth quarter and full year ended December 31, 2015.

17 Feb 2016

Aytu BioScience announces business strategy update and Q2 financial results

Aytu BioScience, Inc., a specialty healthcare company focused on developing treatments for urological and related conditions, provided today an overview of its business and growth strategy, as well as its financial results for the quarter ended December 31, 2015.

17 Feb 2016

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announce that they have entered into distribution, license and supply agreements with Mundipharma and its network of independent associated companies granting exclusive rights to anamorelin in Norway, Finland, Sweden, Denmark and Iceland.

16 Feb 2016

Sphere Medical's new manufacturing facility for Proxima blood gas analyser opens in St. Asaph, Wales

Sphere Medical, an innovator company in critical care monitoring and diagnostics equipment, has opened its new commercial production facility in St. Asaph, Wales.

15 Feb 2016

Business / Finance

Caribou Biosciences grants IDT worldwide rights to commercialize CRISPR-Cas9 reagents

New study shows beneficial effects of fish consumption during pregnancy

WebMD Health reports record revenue, earnings for fourth quarter and full year 2015

Diversigen, Baylor Miraca to provide customers access to targeted genomics and metabolomics services

Regulus reports net loss of $7.2 million for fourth quarter 2015

ResMed announces definitive agreement to acquire Brightree

Amarantus BioScience Holdings closes $3M investment

BistroMD, Fitness Icon Denise Austin partner to create branded meal-delivery program

Select Medical Holdings, Kindred Healthcare agree to exchange five long term acute care hospitals

BiondVax gains additional support from NATI for ongoing development of Universal Flu Vaccine

Corvidia Therapeutics secures $26 million in Series A financing

Enzyme screening kits and samples global distribution agreement signed between Strem and Novozymes

Creating NGS solutions in routine clinical diagnostics

BioTek to be Awarded 2015 Governor’s Excellence in Worksite Wellness

AMRI's net revenues increase $126.4M to 46% in fourth quarter 2015

Asterias Biotherapeutics simplifies capital structure through previously announced Asset Swap with BioTime

CTI BioPharma announces Q4 and FY 2015 earnings

Aytu BioScience announces business strategy update and Q2 financial results

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

Sphere Medical's new manufacturing facility for Proxima blood gas analyser opens in St. Asaph, Wales

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News